The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration

被引:10
|
作者
Gillies, Mark C. [1 ]
Larsson, Jorgen [1 ]
机构
[1] Univ Sydney, Save Sight Inst, Dept Clin Ophthalmol, Sydney, NSW 2001, Australia
关键词
CLINICAL-TRIAL; ACETONIDE;
D O I
10.1016/j.ajo.2007.03.019
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To evaluate the effect of a single intravitreal injection of triamcinolone (IVTA) on central macular thickness and visual acuity in eyes with minimally classic exudative age-related macular degeneration (AMD). DESIGN- Retrospective, nonrandomized clinical interventional study. METHODS: Optical coherence tomography (OCT) and best,corrected logarithm of the minimum angle of resolution visual acuity were performed at baseline and one month after treatment. RESULTS: We identified I I eyes with foveal edema and minimally classic subfoveal neovascularization treated with an IVTA. Foveal edema decreased significantly from 401 98 mu m at baseline to 295 141 mu m (mean standard deviation; P = .004) at one month. There was, however, no significant change in visual acuity at one or three months after the intervention. CONCLUSIONS: This biological effect of IVTA does not support its clinical use, yet it does warrant further research to determine whether locally delivered cortico- steroids may be synergistic with other treatments. Reduction in foveal edema is not necessarily associated with improved visual function in exudative AMD.
引用
收藏
页码:134 / 136
页数:3
相关论文
共 50 条
  • [1] Administration of intravitreal triamcinolone for exudative macular degeneration
    Penfold, PL
    Gyory, JF
    Hunyor, AB
    Billson, FA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 490 - 490
  • [2] Exudative macular degeneration and intravitreal triamcinolone - A pilot study
    Penfold, PL
    Gyory, JF
    Hunyor, AB
    Billson, FA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1995, 23 (04): : 293 - 298
  • [3] Intravitreal triamcinolone acetonide for exudative age related macular degeneration
    Wong, D
    Campbell, I
    Groenwald, C
    Lancaster, E
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (04) : 598 - 598
  • [4] Intravitreal triamcinolone acetonide for exudative age related macular degeneration
    Jonas, JB
    Kreissig, I
    Hugger, P
    Sauder, G
    Panda-Jonas, S
    Degenring, R
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (04) : 462 - 468
  • [5] Intravitreal triamcinolone acetonide in exudative age-related macular degeneration
    Danis, RP
    Ciulla, TA
    Pratt, LM
    Anliker, W
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2000, 20 (03): : 244 - 250
  • [6] Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration
    Jonas, JB
    Akkoyun, I
    Budde, WM
    Kreissig, I
    Degenring, RF
    ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (02) : 218 - 222
  • [7] Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up
    Challa, JK
    Gillies, MC
    Penfold, PL
    Gyory, JF
    Hunyor, ABL
    Billson, FA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1998, 26 (04): : 277 - 281
  • [8] Intravitreal Bevacizumab After Intravitreal Triamcinolone for Exudative Age-Related Macular Degeneration
    Jonas, Jost B.
    Libondi, Teodosio
    Golubkina, Lidia
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2012, 1 (03): : 140 - 141
  • [9] Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes
    Barak, A
    Regenbogen, M
    Goldstein, M
    Loewenstein, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2006, 8 (02): : 83 - 87
  • [10] Duration of the effect of intravitreal triamcinolone acetonide as treatment of exudative age-related macular degeneration
    Jonas, JB
    Degenring, RF
    Kreissig, I
    Akkoyun, I
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U746 - U746